Serum soluble ST2 as diagnostic marker of systemic inflammatory reactive syndrome of bacterial etiology in children

Pediatric Infectious Disease Journal

Volumn 33, Issue 2, 2014, Pages 199-203

  Calò Carducci, Francesca Ippolita ^a   Aufiero, Lelia Rotondi ^a   Folgori, Laura ^a   Vittucci, Anna Chiara ^a   Amodio, Donato ^a   De Luca, Maia ^a   Li Pira, Giuseppina ^a   Bergamini, Alberto ^b   Pontrelli, Giuseppe ^a   Finocchi, Andrea ^a   D'argenio, Patrizia ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

diagnosis; marker; pediatric; systemic inflammatory response syndrome

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 1 RECEPTOR; PROCALCITONIN; ST2 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL INFECTION; COHORT ANALYSIS; COMMUNICABLE DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VIRUS ETIOLOGY;

BIOLOGICAL MARKERS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PROSPECTIVE STUDIES; RECEPTORS, CELL SURFACE; ROC CURVE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84893017654     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000030     Document Type: Article

References (29)

1. King C. Evaluation and management of febrile infants in the emergency department. Emerg Med Clin North Am. 2003;2189-99
2. Ciesla G, Leader S, Stoddard J. Antibiotic prescribing rates in the US ambulatory care setting for patients diagnosed with influenza, 1997-2001. Respir Med. 2004;981093-1101
3. Gaur AH, Hare ME, Shorr RI. Provider and practice characteristics associated with antibiotic use in children with presumed viral respiratory tract infections. Pediatrics. 2005;115635-641
4. Nyquist AC, Gonzales R, Steiner JF, et al. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA. 1998;279875-877
5. Harbarth S, Holeckova K, Froidevaux C, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001;164396-402
6. Simon L, Saint-Louis P, Amre DK, et al. Procalcitonin and C-reactive protein as markers of bacterial infection in critically ill children at onset of systemic inflammatory response syndrome. Pediatr Crit Care Med. 2008;9407-413
7. Jaye DL, Waites KB. Clinical applications of C-reactive protein in pediatrics. Pediatr Infect Dis J. 1997;16735-46; quiz 746
8. Peltola H, Jaakkola M. C-reactive protein in early detection of bacteremic versus viral infections in immunocompetent and compromised children. J Pediatr. 1988;113641-646
9. Tang BM, Eslick GD, Craig JC, et al. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients systematic review and meta-analysis. Lancet Infect Dis. 2007;7210-217
10. Müller B, Christ-Crain M, Schuetz P. Meta-analysis of procalcitonin for sepsis detection. Lancet Infect Dis. 2007;7498-499; author reply 502
11. Reinhart K, Brunkhorst FM. Meta-analysis of procalcitonin for sepsis detection. Lancet Infect Dis. 2007;7500-502; author reply 502
12. Yanagisawa K, Takagi T, Tsukamoto T, et al. Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1receptor type 1. FEBS Lett. 1993;31883-87
13. Tominaga S. A putative protein of a growth specific cDNA from BALB c-3T3 cells is highly similar to the extracellular portion of mouse interleukin1 receptor. FEBS Lett. 1989;258301-304
14. Yanagisawa K, Naito Y, Kuroiwa K, et al. The expression of ST2 gene in helper T cells and the binding of ST2 protein to myeloma-derived RPMI8226cells. J Biochem. 1997;12195-103
15. Xu D, Chan WL, Leung BP, et al. Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med. 1998;187787-794
16. Bergers G, Reikerstorfer A, Braselmann S, et al. Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO J. 1994;131176-1188
17. Hayakawa H, Hayakawa M, Kume A, et al. Soluble ST2 blocks interleukin-33signaling in allergic airway inflammation. J Biol Chem. 2007;28226369-26380
18. Sanada S, Hakuno D, Higgins LJ, et al. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest. 2007;1171538-1549
19. Kumar S, Tzimas MN, Griswold DE, et al. Expression of ST2, an interleukin-1 receptor homologue, is induced by proinflammatory stimuli. Biochem Biophys Res Commun. 1997;235474-478
20. Tajima S, Oshikawa K, Tominaga S, et al. The increase in serum soluble ST2protein upon acute exacerbation of idiopathic pulmonary fibrosis. Chest. 2003;1241206-1214
21. Kuroiwa K, Arai T, Okazaki H, et al. Identification of human ST2 protein in the sera of patients with autoimmune diseases. Biochem Biophys Res Commun. 2001;2841104-1108
22. Weinberg EO, Shimpo M, Hurwitz S, et al. Identification of serum soluble ST2receptor as a novel heart failure biomarker. Circulation. 2003;107721-726
23. Brunner M, Krenn C, Roth G, et al. Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma. Intensive Care Med. 2004;301468-1473
24. Hoogerwerf JJ, Tanck MW, van Zoelen MA, et al. Soluble ST2 plasma concentrations predict mortality in severe sepsis. Intensive Care Med. 2010;36630-637
25. Goldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;62-8
26. Rossi P, Botgros R, et al. Report on the Expert Meeting on Neonatal and Paediatric Sepsis. June 8, 2010. Available at httpwww.ema.europa. eudocsen GBdocument libraryReport201012WC500100199.pdf. Accessed December 16, 2010
27. Campbell G. Advances in statistical methodology for the evaluation of diagnostic and laboratory tests. Stat Med. 1994;13499-508
28. Dieplinger B, Egger M, Koehler W, et al. Prognostic value of soluble ST2 in an unselected cohort of patients admitted to an intensive care unit - The Linz Intensive Care Unit (LICU) study. Clin Chim Acta. 2012;413587-593
29. Liew FY, Xu D, Brint EK, et al. Negative regulation of toll-like receptormediated immune responses. Nat Rev Immunol. 2005;5446-458